https://www.thepharmaletter.com/pharma-news/nice-rejects-alimera-s-iluvien-for-dmo-in-draft-guidance
NICE rejects Alimera's Iluvien for DMO in draft guidance | Pharmaceutical | The Pharmaletter
In draft guidance published today (August 8) by UK drugs watchdog the National Institute for Health and Clinical Excellence (NICE) said it is not recommending N